Insulet Corporation, a leading player in the medical device industry, has been making waves with its innovative insulin delivery systems. Catering to patients with insulin-dependent diabetes, Insulet’s flagship product is the Omnipod System - a self-adhesive and disposable tubeless device that can be worn on the body for up to three days, along with its handheld personal diabetes manager. The Massachusetts-based company has a diverse distribution network, selling its products through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Their incredible growth trajectory can be attributed to the success of their cutting-edge products, which have been embraced by the medical community and end-users alike. Since its incorporation in 2000, Insulet Corporation has undergone significant expansion, and its headquarters remain located in the town of Acton, Massachusetts. Their ongoing commitment to developing new and innovative solutions firmly cements their position as a leader in the field of insulin delivery systems.
Insulet's ticker is PODD
The company's shares trade on the NASDAQ stock exchange
They are based in Acton, Massachusetts
There are 501-1000 employees working at Insulet
It is insulet.com
Insulet is in the Healthcare sector
Insulet is in the Medical Instruments & Supplies industry
The following five companies are Insulet's industry peers: